| |
J Antimicrob Chemother, Vol. 48, No. 5. (1 November 2001), pp. 677-89.
|
| |
Am J Epidemiol, Vol. 156, No. 3. (1 August 2002), pp. 204-10.
|
| |
Jama, Vol. 293, No. 19. (18 May 2005), pp. 2362-6.
|
| |
Bmj, Vol. 327, No. 7423. (8 November 2003), pp. 1083-4.
|
| |
Lancet, Vol. 365, No. 9465. (26 March 2005), pp. 1159-62.
|
| |
J Clin Epidemiol, Vol. 50, No. 10. (1 October 1997), pp. 1089-98.
|
| |
Lancet, Vol. 362, No. 9394. (1 November 2003), pp. 1439-44.
|
| |
Hematol Oncol Clin North Am, Vol. 14, No. 4. (1 August 2000), pp. 973-91.
|
| |
Control Clin Trials, Vol. 20, No. 3. (1 June 1999), pp. 253-66.
|
| |
Control Clin Trials, Vol. 18, No. 5. (1 October 1997), pp. 431-44.
|
| |
J Clin Epidemiol, Vol. 55, No. 6. (1 June 2002), pp. 545-55.
|
| |
Am J Epidemiol, Vol. 148, No. 11. (1 December 1998), pp. 1117-26.
|
| |
BMC Med Res Methodol, Vol. 4 (28 May 2004), 14.
|
| |
J Acquir Immune Defic Syndr Hum Retrovirol, Vol. 16, No. 1. (1 September 1997), pp. 22-30.
|
| |
Cmaj, Vol. 171, No. 10. (9 November 2004), pp. 1179-85.
|
| |
Bmj, Vol. 330, No. 7500. (14 May 2005), 1128.
|
| |
Lancet, Vol. 352, No. 9142. (28 November 1998), pp. 1752-3.
|
| |
Genome Res, Vol. 14, No. 6. (1 June 2004), pp. 1085-94.
|
| |
Nat Genet, Vol. 29, No. 3. (1 November 2001), pp. 306-9.
|